BSE filing, NSE: BANCOINDIA. Summary written from the filing by ALFA Finder's alert engine.
Banco Products (India) Ltd: key numbers
- Share price
- ₹583.15
- Market cap
- ₹8,341 Cr
- Revenue (annual)
- ₹3,896 Cr
- Net profit (annual)
- ₹481.7 Cr
- P/E (TTM)
- 16.9×Sector 31.4×
- Promoter holding
- 67.88%+0.00% QoQ
- FII holding
- 3.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Banco Products (India) Ltd
All →Banco Products (India) Board Meeting Date
Banco Products (India) Limited will hold a board meeting on November 6, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
Banco Products (India) Management Change
Banco Products (India) Ltd announced the resignation of two senior management personnel, Mr. Sujith Nair (President - Marketing) and Mr. Santosh Sawant (DGM - Marketing), effective September 2026.
Banco Products (India) Annual General Meeting
Banco Products (India) held its 65th Annual General Meeting on 19th September 2026. The company discussed financials, director appointments, and a dividend of Rs. 8 per share.
Banco Products (India) Management Change
Banco Products (India) Limited appointed Mr. Kshitikesh Parmeshwar as Chief Technology Officer, effective September 14, 2026.
Banco Products (India) Other Announcement
Banco Products (India) Limited submitted its Business Responsibility and Sustainability Report for the financial year ended 31st March 2026 as per SEBI regulations.
Banco Products (India) Annual Report
Banco Products (India) Ltd. has submitted its 65th Annual Report for the financial year ended March 31, 2026. The report includes the notice for the upcoming AGM.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.